XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANEGS IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
[1]
Preferred Stock
Common Stock
Paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Balance at beginning of period (in shares) at Dec. 31, 2022     0        
Balance at beginning of period at Dec. 31, 2022 $ 230,268 $ (1,198) $ 0 $ 17,598 $ 167,537 $ 111,573 $ (66,440)
Balance at beginning of period (in shares) at Dec. 31, 2022       17,598,123      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income 10,797           10,797
Dividends on common shares (7,722)         (7,722)  
Issuance of restricted stock, net of forfeitures (in shares)       32,351      
Issuance of restricted stock, net of forfeitures 0     $ 32 (32)    
Tax withholding related to vesting of restricted stock (in shares)       (24,811)      
Tax withholding related to vesting of restricted stock (252)     $ (25) (227)    
Repurchase of shares (in shares)       (41,481)      
Repurchase of shares (406)     $ (41) (365)    
Stock-based compensation expense, net 1,701       1,701    
Net income $ 21,747         21,747  
Balance at end of period (in shares) at Dec. 31, 2023 0   0        
Balance at end of period at Dec. 31, 2023 $ 254,935   $ 0 $ 17,564 168,614 124,400 (55,643)
Balance at end of period (in shares) at Dec. 31, 2023 17,564,182     17,564,182      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income $ 8,076           8,076
Dividends on common shares (7,899)         (7,899)  
Issuance of restricted stock, net of forfeitures (in shares)       69,597      
Issuance of restricted stock, net of forfeitures 0     $ 70 (70)    
Tax withholding related to vesting of restricted stock (in shares)       (23,895)      
Tax withholding related to vesting of restricted stock (296)     $ (24) (272)    
Repurchase of shares (in shares)       (90,000)      
Repurchase of shares (1,305)     $ (90) (1,215)    
Stock-based compensation expense, net 1,296       1,296    
Net income $ 23,868         23,868  
Balance at end of period (in shares) at Dec. 31, 2024 0   0        
Balance at end of period at Dec. 31, 2024 $ 278,675   $ 0 $ 17,520 $ 168,353 $ 140,369 $ (47,567)
Balance at end of period (in shares) at Dec. 31, 2024 17,519,884     17,519,884      
[1]
(1) Represents the impact of the adoption of Accounting Standards Update ("ASU") No. 216-13: CECL